The answer is the first one
An example of a scope three carbon emission is; driving a gasoline-fueled vehicle
<h3>What is Scope three carbon emission?</h3>
Scope 3 emissions are a defined as the consequence of the activities of the company that occur from sources not owned or controlled by the company.
Some examples of scope 3 carbon emission activities are;
Extraction and production of purchased materials.
Transportation of purchased fuels.
Use of products and services.
Thus, when applied in practical, we can say that an example of a scope three carbon emission is; driving a gasoline-fueled vehicle
Read more about carbon emissions at; brainly.com/question/1301348
#SPJ1
<h3>answer. she can grade 72 papers in 8 hours</h3>
Explanation:
hope you do well
Answer:
Cancer is the name given to a collection of related diseases. Cancer is more than one type of disease. In cancer, as a result of genetic mutations, this regulatory process malfunctions, resulting in uncontrolled cell proliferation. CAD, Stroke, Respiratory illness, COPD are all diseases related to cancer. Inherited genetic mutations play a major role in about 5 to 10 percent of all cancers. There are many environmental pathogenic factors that can cause cancer. For example , Tar and Coal-Tar Pitch , Emissions , Secondhand Tobacco Smoke (Environmental Tobacco Smoke) , Arsenic , Soot , Asbestos , Wood Dust. When cancer cells break away from a tumor, they can travel to other parts of the body through the bloodstream or the lymph system. Cancer is hard to treat in later stages because it probably has already spread through out the body. The grade of a cancer depends on what the cells look like under a microscope. In general, a lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Some examples of cancer treatments of cancer are, Surgery, Chemotherapy, Radiotherapy, Cancer drugs, Hormone therapy, Stem cell and bone marrow transplants, Targeted cancer drugs. A new treatment involving a photosensitising agent that makes cells more sensitive to light and, by doing so, causes cancer cells to
be destroyed when a laser light is directed on a cancerous area. One challenge is, druggable genomic alterations are diverse and represent only small subsets of patients in certain tumor types, which limits testing their clinical impact in biomarker-driven clinical trials. Next-generation sequencing technologies are increasingly being implemented for molecular prescreening in clinical research, but issues regarding clinical interpretation of large genomic data make their wide clinical use difficult.
Explanation:
Sometimes I play that game
